- Home
- ETON vs RA Comparison
ETON vs RA Comparison
Compare ETON & RA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ETON | RA |
|---|---|---|
| Founded | 2017 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 872.7M | 702.3M |
| IPO Year | 2018 | 2016 |
Fundamental Metrics
Financial Performance| Metric | ETON | RA |
|---|---|---|
| Price | $37.07 | $12.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 406.6K | 141.9K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.05 | N/A |
| Revenue | ★ $79,950,000.00 | N/A |
| Revenue This Year | $40.90 | N/A |
| Revenue Next Year | $47.23 | N/A |
| P/E Ratio | $741.40 | ★ N/A |
| Revenue Growth | ★ 104.94 | N/A |
| 52 Week Low | $13.78 | $12.50 |
| 52 Week High | $39.48 | $13.59 |
Technical Indicators
Market Signals| Indicator | ETON | RA |
|---|---|---|
| Relative Strength Index (RSI) | 59.36 | 58.09 |
| Support Level | $15.77 | $12.82 |
| Resistance Level | $38.62 | $12.98 |
| Average True Range (ATR) | 1.59 | 0.11 |
| MACD | -0.14 | 0.01 |
| Stochastic Oscillator | 47.95 | 67.74 |
Price Performance
Historical ComparisonAbout ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
About RA Brookfield Real Assets Income Fund Inc.
Brookfield Real Assets Income Fund Inc. is a diversified, closed-end management investment company. The investment objective of the Fund is to seek high total return, through high current income and secondarily, through growth of capital. The Fund seeks to achieve its investment objective by investing in the real asset class, which includes the following: Real Estate Securities, Infrastructure Securities, and Natural Resources Securities. The Fund operates in a single operating segment.